These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 6725182

  • 21. Disseminated Mycobacterium chelonei infection: response to sulfonamides.
    Tice AD, Solomon RJ.
    Am Rev Respir Dis; 1979 Jul; 120(1):197-201. PubMed ID: 464378
    [Abstract] [Full Text] [Related]

  • 22. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
    Wallace RJ, Hull SI, Bobey DG, Price KE, Swenson JM, Steele LC, Christensen L.
    Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
    [Abstract] [Full Text] [Related]

  • 23. Mycobacterium triplex pulmonary disease with acquired macrolide resistance in immunocompetent patients.
    Matsuda S, Suzuki S, Morimoto K, Aono A, Nishio K, Asakura T, Sasaki Y, Namkoong H, Nishimura T, Ogata H, Hasegawa N, Kurashima A, Ishii M, Tatsumi K, Mitarai S, Goto H.
    Clin Microbiol Infect; 2018 Jun; 24(6):671-672. PubMed ID: 29309938
    [No Abstract] [Full Text] [Related]

  • 24. Osteomyelitis, pericarditis, mediastinitis, and vasculitis due to mycobacterium chelonei.
    Jauregui L, Arbulu A, Wilson F.
    Am Rev Respir Dis; 1977 Apr; 115(4):699-703. PubMed ID: 848795
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Mycobacterium brisbanense lung infection facilitated by steroid induced adrenal insufficiency.
    Gynthersen R, Qvist T, Andersen ÅB, Katzenstein TL.
    APMIS; 2019 Feb; 127(2):106-108. PubMed ID: 30585355
    [Abstract] [Full Text] [Related]

  • 33. Atypical mycobacteria: an important differential for the general physician.
    Rahama O, Thaker H.
    Clin Med (Lond); 2013 Oct; 13(5):504-6. PubMed ID: 24115711
    [No Abstract] [Full Text] [Related]

  • 34. NTM drug discovery: status, gaps and the way forward.
    Wu ML, Aziz DB, Dartois V, Dick T.
    Drug Discov Today; 2018 Aug; 23(8):1502-1519. PubMed ID: 29635026
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antimycobacterial strategies to evade antimicrobial resistance in the nontuberculous mycobacteria.
    Millar BC, Moore JE.
    Int J Mycobacteriol; 2019 Aug; 8(1):7-21. PubMed ID: 30860173
    [Abstract] [Full Text] [Related]

  • 38. Antibiotic resistance in Mycobacterium Abscessus and Mycobacterium Fortuitum isolates from Malaysian patients.
    Jayasingam SD, Zin T, Ngeow YF.
    Int J Mycobacteriol; 2017 Aug; 6(4):387-390. PubMed ID: 29171453
    [Abstract] [Full Text] [Related]

  • 39. Pulmonary infection with nontuberculous mycobacteria.
    Contreras MA, Cheung OT, Sanders DE, Goldstein RS.
    Am Rev Respir Dis; 1988 Jan; 137(1):149-52. PubMed ID: 3337456
    [Abstract] [Full Text] [Related]

  • 40. Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.
    Somoskovi A, Salfinger M.
    Clin Lab Med; 2014 Jun; 34(2):271-95. PubMed ID: 24856528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.